FDA’s approval of Friedreich’s ataxia drug is a game changer for treatment of rare diseases
A drug to treat a rare neurological disorder has only had to jump through one hoop—read: clinical trial—instead of the recommended two to win regulatory approval.Read more...
https://qz.com/fda-approval-friedreich-s-ataxia-drug-reata-skyclarys-1850171937
0 notes